Bio Green Med Solution (BGMS) Liabilities and Shareholders Equity (2010 - 2026)

Bio Green Med Solution (BGMS) has reported Liabilities and Shareholders Equity for 17 consecutive years, with $7.6 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Liabilities and Shareholders Equity rose 102.57% year-over-year to $7.6 million; the TTM figure through Mar 2026 stood at $28.3 million (up 32.29% YoY), while the FY2025 annual figure was $8.2 million, up 99.93% from the prior year.
• Liabilities and Shareholders Equity fell to $7.6 million in Q1 2026 per BGMS's latest filing, from $8.2 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $40.2 million in Q1 2022 and bottomed at $3.7 million in Q1 2025.
• Historically, Liabilities and Shareholders Equity has averaged $14.9 million across 5 years, with a median of $8.2 million in 2024.
• Annual changes were most pronounced in 2024 — Liabilities and Shareholders Equity plunged 72.73% — and 2026, when it jumped 102.57%.
• Bio Green Med Solution's Liabilities and Shareholders Equity stood at $28.0 million in 2022, then slumped by 68.61% to $8.8 million in 2023, then sank by 53.5% to $4.1 million in 2024, then jumped by 99.93% to $8.2 million in 2025, then dropped by 7.59% to $7.6 million in 2026.
• Business Quant data shows BGMS's Liabilities and Shareholders Equity at $7.6 million in Q1 2026, $8.2 million in Q4 2025, and $8.2 million in Q3 2025.